Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)

Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗

Topics ETFs Stocks

November 04, 2025

Via Benzinga

Sarepta Therapeutics Stock Crashes After-Hours On DMD Trial Failure, Q3 Print — Retail Still Sees Long-Term Comeback ↗

November 03, 2025

Sarepta shares are plunging in extended trading Monday after the company reports third-quarter results and provided an update on its ESSENCE study.

Sarepta Therapeutics Stock Is Tumbling After The Close: Here's Why ↗

November 03, 2025

Via Benzinga

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

A Peek at Sarepta Therapeutics's Future Earnings ↗

October 31, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

November 03, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Sarepta Crashes After Two Muscular Dystrophy Drugs Fail Confirmatory Tests ↗

November 03, 2025

Sarepta stock crashed Monday after the biotech company said two of its muscular dystrophy drugs failed confirmatory tests.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 03, 2025

Via Benzinga

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE

November 03, 2025

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Via Benzinga

Sarepta Therapeutics to Announce Third Quarter 2025 Financial Results

October 27, 2025

New York, NY – October 23, 2025 – Tradr, a prominent innovator in the Exchange-Traded Fund (ETF) market, has today significantly expanded its product suite with the launch of nine new single-stock 2X...

Tradr Unleashes 2X Single-Stock Gold ETFs, Reshaping Short-Term Gold Investment Landscape

October 23, 2025

Tradr Launches 9 Single-Stock 2X ETFs With First-Of-Its-Kind OpenDoor, Gold And AI Exposure ↗

Topics Artificial Intelligence Derivatives ETFs

October 23, 2025

The new ETFs include the first-of-their-kind gold and AI plays, giving traders targeted exposure without using margin or complex options.

Via Benzinga

Topics Artificial Intelligence ETFs

Tradr Debuts Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF ↗

October 23, 2025

Funds seek to provide 200% long exposure on a variety of industry leaders

Sarepta prepares to present new data on Duchenne and limb-girdle muscular dystrophy gene therapy programs this week.

Topics ETFs

What's Going On Sarepta Stock On Wednesday? ↗

October 08, 2025

Via Benzinga

Why Sarepta Therapeutics Stock Is Rising Nearly 5% Premarket ↗

October 08, 2025

Investors turned upbeat ahead of Sarepta’s data presentations in Vienna, where the company is expected to share new Duchenne muscular dystrophy results and updates from its broader gene therapy...

Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data

Topics Death

October 03, 2025

Boston, MA – October 3, 2025 – Leap Therapeutics, Inc. (NASDAQ: LPTX) experienced a sharp downturn in its stock performance today, with shares falling by over 20% in intraday trading. This significant...

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress

October 03, 2025

Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday ↗

October 02, 2025

U.S. stocks were mixed, with the Dow Jones index falling more than 50 points on Thursday.

Via Benzinga

Topics Stocks

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 30, 2025

Incannex Healthcare (NASDAQ: IXHL) Braces for Volatility as Q4 Earnings Loom: Options Traders Eye Strategic Plays

September 27, 2025

Melbourne, Australia – September 27, 2025 – Incannex Healthcare Limited (NASDAQ: IXHL) is on the cusp of a pivotal week, with its Q4 2025 earnings report scheduled for release on Monday, September 29,...

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

Topics Artificial Intelligence Earnings

This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

September 22, 2025

Via Benzinga

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NASDAQ:SRPT),(NASDAQ:AUTL),(NASDAQ:ARCT) EQNX::TICKER_END

Topics Artificial Intelligence Economy Intellectual Property

Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth

September 15, 2025

Via Investor Brand Network

Topics Artificial Intelligence Intellectual Property

Expert Outlook: Sarepta Therapeutics Through The Eyes Of 43 Analysts ↗

September 15, 2025

Via Benzinga

Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth

September 15, 2025

Via FinancialNewsMedia

Topics Artificial Intelligence Intellectual Property

2 Beaten-Down Stocks to Avoid Right Now ↗

September 05, 2025

These once high-flying stocks no longer seem to have promising prospects.

Via The Motley Fool

Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2025-2026 Academic Year

September 05, 2025